165 related articles for article (PubMed ID: 37926706)
1. m
Wei H; Yang J; Lu R; Huang Y; Huang Z; Huang L; Zeng M; Wei Y; Xu Z; Li W; Pu J
Sci Rep; 2023 Nov; 13(1):19124. PubMed ID: 37926706
[TBL] [Abstract][Full Text] [Related]
2. N
Pu J; Xu Z; Huang Y; Nian J; Yang M; Fang Q; Wei Q; Huang Z; Liu G; Wang J; Wu X; Wei H
Cancer Sci; 2023 Sep; 114(9):3649-3665. PubMed ID: 37400994
[TBL] [Abstract][Full Text] [Related]
3. METTL3 and METTL14-mediated N
Wu X; Zeng M; Wei Y; Lu R; Huang Z; Huang L; Huang Y; Lu Y; Li W; Wei H; Pu J
Sci Rep; 2024 Mar; 14(1):6155. PubMed ID: 38486042
[TBL] [Abstract][Full Text] [Related]
4. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
Xu Y; Zheng Y; Liu H; Li T
Int J Oncol; 2017 Sep; 51(3):791-800. PubMed ID: 28677801
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive profiling of novel microRNA-9 targets and a tumor suppressor role of microRNA-9 via targeting IGF2BP1 in hepatocellular carcinoma.
Zhang J; Cheng J; Zeng Z; Wang Y; Li X; Xie Q; Jia J; Yan Y; Guo Z; Gao J; Yao M; Chen X; Lu F
Oncotarget; 2015 Dec; 6(39):42040-52. PubMed ID: 26547929
[TBL] [Abstract][Full Text] [Related]
6. METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m
Dai YZ; Liu YD; Li J; Chen MT; Huang M; Wang F; Yang QS; Yuan JH; Sun SH
Cell Mol Biol Lett; 2022 May; 27(1):41. PubMed ID: 35596159
[TBL] [Abstract][Full Text] [Related]
7. miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
Zhou X; Zhang CZ; Lu SX; Chen GG; Li LZ; Liu LL; Yi C; Fu J; Hu W; Wen JM; Yun JP
Oncogene; 2015 Feb; 34(8):965-77. PubMed ID: 24632613
[TBL] [Abstract][Full Text] [Related]
8. N
Tan C; Huang Y; Huang Z; Ning Y; Huang L; Wu X; Lu Y; Wei H; Pu J
J Hepatocell Carcinoma; 2023; 10():1479-1495. PubMed ID: 37701563
[TBL] [Abstract][Full Text] [Related]
9. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression.
Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z
Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595
[TBL] [Abstract][Full Text] [Related]
10. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC.
Habashy DA; Hamad MHM; Ragheb M; Khalil ZA; El Sobky SA; Hosny KA; Esmat G; El-Ekiaby N; Fawzy IO; Abdelaziz AI
Life Sci; 2022 Dec; 310():121075. PubMed ID: 36243115
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m
Bo C; Li N; He L; Zhang S; An Y
Hum Cell; 2021 Nov; 34(6):1843-1854. PubMed ID: 34491544
[TBL] [Abstract][Full Text] [Related]
12. M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma.
Du A; Li S; Zhou Y; Disoma C; Liao Y; Zhang Y; Chen Z; Yang Q; Liu P; Liu S; Dong Z; Razzaq A; Tao S; Chen X; Liu Y; Xu L; Zhang Q; Li S; Peng J; Xia Z
Mol Cancer; 2022 May; 21(1):109. PubMed ID: 35524319
[TBL] [Abstract][Full Text] [Related]
13. LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2.
Jia G; Wang Y; Lin C; Lai S; Dai H; Wang Z; Dai L; Su H; Song Y; Zhang N; Feng Y; Tang B
J Exp Clin Cancer Res; 2021 Sep; 40(1):299. PubMed ID: 34551796
[TBL] [Abstract][Full Text] [Related]
14. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2'-O methylation.
Zhu Y; Xiao B; Liu M; Chen M; Xia N; Guo H; Huang J; Liu Z; Wang F
Cell Mol Biol Lett; 2023 Oct; 28(1):89. PubMed ID: 37891494
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1.
Jiang T; Li M; Li Q; Guo Z; Sun X; Zhang X; Liu Y; Yao W; Xiao P
Oncol Res; 2017 Aug; 25(7):1117-1127. PubMed ID: 28244848
[TBL] [Abstract][Full Text] [Related]
16. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma.
Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S
Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222
[TBL] [Abstract][Full Text] [Related]
17. LIN28B-AS1-IGF2BP1 binding promotes hepatocellular carcinoma cell progression.
Zhang J; Hu K; Yang YQ; Wang Y; Zheng YF; Jin Y; Li P; Cheng L
Cell Death Dis; 2020 Sep; 11(9):741. PubMed ID: 32917856
[TBL] [Abstract][Full Text] [Related]
18. N
Liu J; Zhang N; Zeng J; Wang T; Shen Y; Ma C; Yang M
Clin Transl Med; 2022 Nov; 12(11):e1107. PubMed ID: 36354136
[TBL] [Abstract][Full Text] [Related]
19. Downregulated liver-elevated long intergenic noncoding RNA (LINC02428) is a tumor suppressor that blocks KDM5B/IGF2BP1 positive feedback loop in hepatocellular carcinoma.
Du X; Zhou P; Zhang H; Peng H; Mao X; Liu S; Xu W; Feng K; Zhang Y
Cell Death Dis; 2023 May; 14(5):301. PubMed ID: 37137887
[TBL] [Abstract][Full Text] [Related]
20. miR‑23b inhibits proliferation of SMMC‑7721 cells by directly targeting IL‑11.
Jiang T; Huang Z; Zhang S; Zou W; Xiang L; Wu X; Shen Y; Liu W; Zeng Z; Zhao A; Zhou S; Zeng Q
Mol Med Rep; 2018 Aug; 18(2):1591-1599. PubMed ID: 29901200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
